| Financial Year |
March 31 2023 |
| Monetary Funds |
5,163,453,488.47 |
| Held-for-trading Financial Assets |
701,577.01 |
| Notes Receivable |
1,168,500.00 |
| Accounts Receivable |
2,296,929,340.13 |
| Advances to Suppliers |
375,060,291.14 |
| Other Receivables |
10,883,851.22 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,925,811,376.83 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
51,893,707.76 |
| Total Current Assets |
11,865,607,570.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
296,080,013.61 |
| Investment Properties |
51,834,515.29 |
| Fixed Assetes |
2,655,467,395.65 |
| Under-construction Projects |
238,291,997.16 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
219,428,291.23 |
| R&D expenses |
-- |
| Goodwill |
31,882.96 |
| Long-Term Deferred and Prepaid Expenses |
33,122,325.34 |
| Deferred Income Tax Assets |
38,283,850.97 |
| Other Non-Current Assets |
78,913,182.74 |
| Sub-Total of Non-Current Assets |
8,161,391,343.14 |
| Total Assets |
20,026,998,913.61 |
| Short-Term Loans |
2,577,022,848.62 |
| Trading Financial liabilities |
34,231.80 |
| Notes Payable |
2,245,407,662.71 |
| Accounts Payable |
2,400,516,521.08 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
253,357,518.91 |
| Taxes Payable |
68,115,651.05 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
388,142,973.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,345,305,740.47 |
| Other Current Liabilities |
56,619,274.47 |
| Sub-Total of Current Liabilities |
9,750,886,873.77 |
| Long-term Loans |
124,624,333.49 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
644,261,816.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
17,440,057.87 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,104,135,926.48 |
| Total Liabilities |
10,855,022,800.25 |
| Paid-In Capital(Or Share Stock) |
3,303,791,344.00 |
| Capital Surplus |
2,505,238,535.62 |
| Surplus Reserve |
712,150,987.67 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,497,534,373.45 |
| Minority Stockholder's Interest |
215,151,081.39 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,956,825,031.97 |
| Owner's Equity（Stockholder's Equity） |
9,171,976,113.36 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
20,026,998,913.61 |
